C.ANIRUDH JAGANNADH, M.SRAVANI, DR M.D DHANARAJU. ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA/GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS. ijpbs [Internet]. 2013 Jun. 30 [cited 2026 Sep. 3];4(2):750-4. Available from: https://ijpbs.net/index.php/journal/article/view/2225